Harmony Biosciences is trading at $42.02 (0%), with no meaningful pre-market change versus the September 18 close.

  • No fresh September 21 company-specific catalyst was identified; recent coverage centers on earlier conference updates and insider selling.
  • Broader U.S. markets are higher, but Harmony Biosciences is not participating in that risk-on move.
  • The available evidence does not establish a specific reason for today’s movement.